Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population and in a large proportion of those the trigger remains undetermined. Antiphospholipid antibodies (aPL) are recognised risk factors for ischaemic stroke and recurrent thrombotic events; however, the frequency of aPL in young people with CVE is still an unresolved issue.
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
SCIASCIA, Savino;
2014-01-01
Abstract
Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population and in a large proportion of those the trigger remains undetermined. Antiphospholipid antibodies (aPL) are recognised risk factors for ischaemic stroke and recurrent thrombotic events; however, the frequency of aPL in young people with CVE is still an unresolved issue.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
aPL and CVA V1D.doc
Accesso riservato
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
324 kB
Formato
Microsoft Word
|
324 kB | Microsoft Word | Visualizza/Apri Richiedi una copia |
35_24942381_4aperto.pdf
Open Access dal 02/10/2015
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
802.87 kB
Formato
Adobe PDF
|
802.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.